The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. Stocks on the Move-Keryx, GlaxoSmithKline, Astrazeneca

Mon, 08th Sep 2014 10:36

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for more market insights,including options activity, ; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stock index e-mini futures fell on Monday: Dow Jonesindustrial average futures were down 0.15 percent at17,091, S&P 500 futures were down 0.16 percent at2,002.75 and Nasdaq 100 futures were down 0.11 percent at4,082.

** KERYX BIOPHARMACEUTICALS INC, Friday close$17.01, -4.59 pct premarket

Keryx Biopharmaceuticals won U.S. approval for its drug tolower phosphate levels in patients with chronic kidney disease(CKD), but the approval included an unexpected safety warning onthe label.

** GLAXOSMITHKLINE PLC, Friday close $47.92, -3.44pct premarket

An experimental Ebola vaccine similar to one being developedby GlaxoSmithKline is effective for at least five weeksin lab monkeys but requires boosting with an additional vaccineto extend its protection to 10 months, according to a studypublished on Sunday.

** ASTRAZENECA PLC, Friday close $74.74, -2.30 pctpremarket

An experimental drug from AstraZeneca - part of anew wave of injectable respiratory drugs designed for people whodo not respond adequately to traditional inhalers - has shownmixed results in chronic lung disease.

** GENERAL ELECTRIC CO, Friday close $26.1

** WHIRLPOOL CORP, Friday close $152.01

Sweden's AB Electrolux said it would buy GeneralElectric's appliances business for $3.3 billion in cash todouble sales in North America and take on rival Whirlpool in itsbiggest ever deal.

** BOEING CO, Friday close $124.69

Boeing and Ryanair Holdings Plc plan to make asignificant fleet announcement on Monday, following reports lastFriday that the low-cost Irish airline was poised to place a $10billion order for Boeing's new 737 MAX jetliner.

** CARLYLE GROUP LP, Friday close $32.62

Carlyle Group, one of the world's largest private equityfirms, said it had closed its fourth Asia fund at $3.9 billion,the second-largest private equity fund ever raised for Asiainvestments.

** FMC CORP, Friday close $65.6

Auriga Industries has agreed to sell its cropprotection unit, Cheminova, to U.S.-based chemicals firm FMC for10.5 billion Danish crowns ($1.8 billion), the Danish companysaid.

** WALGREEN CO, Friday close $63.95

The U.S. drugstore chain operator said it had appointedBarry Rosenstein of hedge fund Jana Partners to its board as thecompany moves to complete its takeover of drugstore chainAlliance Boots.

** GENERAL MOTORS CO, Friday close $34.58

The company will introduce in two years its first car thatcan communicate with other vehicles to help avoid accidents andease traffic congestion, Chief Executive Mary Barra said onSunday. (Reporting By Shubhankar Chakravorty in Bangalore; Editing bySimon Jennings)

More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.